← Back to Search

Virus Testing

Saliva test kit for Coronavirus

N/A
Waitlist Available
Led By Manisha Desai, PhD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 days per participant
Awards & highlights

Study Summary

This trial will help determine if a saliva-based test can be used to monitor for SARS-CoV-2 infection at home.

Eligible Conditions
  • Coronavirus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 days per participant
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 days per participant for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Matched Test Colormetric Interpretation as a Measure of Interrater Reliability
Number of Positive Home Saliva Tests as Determined by the Patient
Secondary outcome measures
Number of Participants That Called Technical Support
Participant-rated Confidence in Interpreting Results
Participant-rated Ease of Use
+3 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Saliva testExperimental Treatment1 Intervention
Participants perform each test assay, noting the results for comparison by technician, and completing survey questionnaires.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Saliva test kit
2020
N/A
~1280

Find a Location

Who is running the clinical trial?

BIOBOXUNKNOWN
Stanford UniversityLead Sponsor
2,408 Previous Clinical Trials
17,342,175 Total Patients Enrolled
Manisha Desai, PhDPrincipal InvestigatorStanford University
1 Previous Clinical Trials
122 Total Patients Enrolled
~284 spots leftby Jun 2025